Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for the Treatment of Alcohol Use Disorder
NCT05134857Phase 2Active, not recruiting
- Sponsor
- Washington State University
- Start
- Jan 2022
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Zonisamide + Standard Treatment with Placebo + Standard Treatment (2 arms). Primary endpoint: Change in Self Reported Alcohol Consumption at 1 year. Started Jan 2022; status: active, not recruiting.
02
Drugs
zonisamide
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05134857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134857.